Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application
Data up to Jan 2025
Total Citations Per Year
Abstract
References (48)
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 • 5,487 citations
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
2003 • 3,497 citations
Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually
1989 • 3,239 citations
Validation of the Framingham Coronary Heart Disease Prediction Scores
2001 • 2,076 citations
A breast cancer prediction model incorporating familial and personal risk factors
2004 • 1,203 citations
A general cardiovascular risk profile: The Framingham study
1976 • 1,165 citations
Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction
1994 • 955 citations
Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer
1999 • 866 citations
Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals
2002 • 829 citations
Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2
1998 • 743 citations
Validation Studies for Models Projecting the Risk of Invasive and Total Breast Cancer Incidence
1999 • 743 citations
Assessment and comparison of prognostic classification schemes for survival data
1999 • 735 citations
BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer
1997 • 693 citations
Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer
1999 • 676 citations
Primary Prevention of Coronary Heart Disease: Guidance From Framingham
1998 • 618 citations
Variations in Lung Cancer Risk Among Smokers
2003 • 610 citations
Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals
2002 • 517 citations
BRCAPRO Validation, Sensitivity of Genetic Testing of BRCA1/BRCA2, and Prevalence of Other Breast Cancer Susceptibility Genes
2002 • 505 citations
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
2002 • 483 citations
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
1998 • 468 citations
The BOADICEA model of genetic susceptibility to breast and ovarian cancer
2004 • 459 citations
Cumulative Risk of Breast Cancer to Age 70 Years According to Risk Factor Status: Data from the Nurses' Health Study
2000 • 443 citations
Clinical Findings with Implications for Genetic Testing in Families with Clustering of Colorectal Cancer
1998 • 402 citations
BRCA1 Sequence Analysis in Women at High Risk for Susceptibility Mutations
1997 • 380 citations
Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention.
2000 • 298 citations
Estimates of the Number of U.S. Women Who Could Benefit From Tamoxifen for Breast Cancer Chemoprevention
2003 • 262 citations
The Prevalence of Common BRCA1 and BRCA2 Mutations among Ashkenazi Jews
1999 • 218 citations
Nurses' Health Study: Log-Incidence Mathematical Model of Breast Cancer Incidence
1996 • 213 citations
Prediction of pathogenic mutations in patients with early-onset breast cancer by family history
2003 • 201 citations
The calculation of breast cancer risk for women with a first degree family history of ovarian cancer
1993 • 192 citations
Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study
2002 • 166 citations
Using Risk for Advanced Proximal Colonic Neoplasia To Tailor Endoscopic Screening for Colorectal Cancer
2003 • 158 citations
PRACTICAL GUIDE FOR ESTIMATING RISK FOR FAMILIAL BREAST CANCER
1983 • 139 citations
Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL
1999 • 120 citations
Risk of familial breast cancer
1985 • 116 citations
A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families
2001 • 114 citations
A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center
2000 • 111 citations
Revisions in the risk-based breast cancer screening program at group health cooperative
1990 • 87 citations
Rates and risks of ovarian cancer in subgroups of white women in the United States. The Collaborative Ovarian Cancer Group.
1994 • 84 citations
Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing
2001 • 76 citations
Development of a decision-making tool to predict risk of prostate cancer: The cancer of the prostate risk index (CAPRI) test
1997 • 44 citations
Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)
2003 • 42 citations
Modeling familial clustered breast cancer using published data.
2003 • 34 citations
Prostate cancer risk assessment program. A model for the early detection of prostate cancer.
1999 • 25 citations
Estimation of individualized probabilities of developing breast cancer for Japanese women
2003 • 19 citations
A simple tool for identifying unaffected women at a moderately increased or potentially high risk of breast cancer based on their family history
2003 • 17 citations
Nomograms and instruments for the initial prostate evaluation: The ability to estimate the likelihood of identifying prostate cancer
2002 • 17 citations
Prostate Cancer Risk Assessment Program
1999 • 13 citations
Cited By (0)
No citing papers found in database